| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormal CD25 expression on hematopoietic cells in myelodysplastic syndromes
|
Liu, Pei
|
|
2018
|
67 |
C |
p. 12-16
|
artikel
|
| 2 |
Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience
|
Dholaria, Bhagirathbhai R.
|
|
2018
|
67 |
C |
p. 1-5
|
artikel
|
| 3 |
Association of red cell distribution width with clinical outcomes in myelodysplastic syndrome
|
Baba, Yuta
|
|
2018
|
67 |
C |
p. 56-59
|
artikel
|
| 4 |
Corrigendum to: Comparison of Induction Therapy in Non-high Risk Acute Promyelocytic Leukemia with Arsenic Trioxide or in Combination with ATRA Leukemia Research 66 (2018) 85–88
|
Ghavamzadeh, Ardeshir
|
|
2018
|
67 |
C |
p. 116
|
artikel
|
| 5 |
Editorial Board
|
|
|
2018
|
67 |
C |
p. ii
|
artikel
|
| 6 |
Efficacy and safety of nilotinib 300 mg twice daily in patients with chronic myeloid leukemia in chronic phase who are intolerant to prior tyrosine kinase inhibitors: Results from the Phase IIIb ENESTswift study
|
Hiwase, Devendra
|
|
2018
|
67 |
C |
p. 109-115
|
artikel
|
| 7 |
Helios expression in regulatory T cells promotes immunosuppression, angiogenesis and the growth of leukemia cells in pediatric acute lymphoblastic leukemia
|
Li, Xue
|
|
2018
|
67 |
C |
p. 60-66
|
artikel
|
| 8 |
Identification of chronic myeloid leukemia patients treated with imatinib who are potentially eligible for treatment discontinuation by assessing real-life molecular responses on the international scale in a EUTOS-certified lab
|
Heinrichs, Amélie
|
|
2018
|
67 |
C |
p. 27-31
|
artikel
|
| 9 |
Iron overload in lower international prognostic scoring system risk patients with myelodysplastic syndrome receiving red blood cell transfusions: Relation to infections and possible benefit of iron chelation therapy
|
Wong, Colleen A.C.
|
|
2018
|
67 |
C |
p. 75-81
|
artikel
|
| 10 |
Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation
|
Wang, Yan-Hua
|
|
2018
|
67 |
C |
p. 99-108
|
artikel
|
| 11 |
PD-1 /PD-L1 checkpoint in hematological malignancies
|
Annibali, O.
|
|
2018
|
67 |
C |
p. 45-55
|
artikel
|
| 12 |
Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS
|
de Swart, Louise
|
|
2018
|
67 |
C |
p. 21-26
|
artikel
|
| 13 |
Prognostic significance of SOX2, SOX3, SOX11, SOX14 and SOX18 gene expression in adult de novo acute myeloid leukemia
|
Tosic, Natasa
|
|
2018
|
67 |
C |
p. 32-38
|
artikel
|
| 14 |
Prognostic significance of The Wilms’ Tumor-1 (WT1) rs16754 polymorphism in acute myeloid leukemia
|
Petiti, Jessica
|
|
2018
|
67 |
C |
p. 6-11
|
artikel
|
| 15 |
Pulmonary Langerhans cell histiocytosis, acute myeloid leukemia, and myelofibrosis in a large family and review of the literature
|
Blakley, Matthew P.
|
|
2018
|
67 |
C |
p. 39-44
|
artikel
|
| 16 |
Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms
|
Mughal, Tariq I.
|
|
2018
|
67 |
C |
p. 67-74
|
artikel
|
| 17 |
Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)
|
Advani, Anjali S.
|
|
2018
|
67 |
C |
p. 17-20
|
artikel
|
| 18 |
The impact of the neutrophil:lymphocyte ratio in response and survival of patients with de novo diffuse large B-cell lymphoma
|
Beltrán, Brady E.
|
|
2018
|
67 |
C |
p. 82-85
|
artikel
|
| 19 |
The importance of meaningful activity in people living with acute myeloid leukemia
|
Deckert, Amy L.
|
|
2018
|
67 |
C |
p. 86-91
|
artikel
|
| 20 |
Widespread use of measurable residual disease in acute myeloid leukemia practice
|
Epstein-Peterson, Zachary D.
|
|
2018
|
67 |
C |
p. 92-98
|
artikel
|
Tijdschrift beschrijving